Skip to main content
OpenTrials

Clinical trial condition

Lymphoma, Mantle-Cell

Explore clinical trials studying Lymphoma, Mantle-Cell. Study availability and eligibility vary by location and protocol.

889 public trials 111 recruiting studies
Refine in advanced search Browse all conditions

Lymphoma, Mantle-Cell trial results

Completed

An Investigational Study Drug, Palbociclib (PD-0332991), Is Being Studied In Patients With Mantle Cell Lymphoma. Patients Must Have Received Prior Treatment(s) For Mantle Cell Lymphoma.

NCT00420056

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations
  • Brigham & Women's Hospital Boston, Massachusetts, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • Memorial Sloan-Kettering Cancer Center New York, United States
  • New York Presbyterian Hospital New York, United States
View Trial Details
Completed

Fludarabine, Cyclophosphamide, and Total-Body Irradiation in Treating Patients Who Are Undergoing a Donor Bone Marrow Transplant for Hematologic Cancer

NCT00134004

Conditions
Blood Coagulation Disorders, Blood Platelet Disorders, Blood Protein Disorders, +63 more
Locations
  • Blood and Marrow Transplant Program at Northside Hospital Atlanta, Georgia, United States
  • Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States
  • Hahnemann University Hospital Philadelphia, Pennsylvania, United States
View Trial Details
Completed

Everolimus in Treating Patients With Relapsed or Refractory Mantle Cell Lymphoma

NCT00516412

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations
  • CHU de Grenoble - Hopital de la Tronche Grenoble, France
  • Hopital Haut Leveque Pessac, France
  • Centre Hospitalier Universitaire Bretonneau de Tours Tours, France
  • Institut Gustave Roussy Villejuif, France
View all 21 locations
View Trial Details

Related conditions